Difference between revisions of "Pertuzumab and Trastuzumab hyaluronidase (Phesgo)"
Jump to navigation
Jump to search
m |
m (Jwarner moved page Pertuzumab & Trastuzumab hyaluronidase (Phesgo) to Pertuzumab and Trastuzumab hyaluronidase (Phesgo): Scrub the ampersand) |
(No difference)
| |
Revision as of 17:49, 8 June 2023
General information
A combination of pertuzumab and trastuzumab, to be given by subcutaneous injection
History of changes in FDA indication
- 2020-06-29: Initial FDA approval
History of changes in EMA indication
- 2020-12-21: Initial authorization
Also known as
- Generic name: pertuzumab/trastuzumab/hyaluronidase-zzxf
- Brand name: Phesgo